Call for Your FREE Evaluation (877) 503-1595

Pharmaceutical and Medical Device News

Areas of Practice

Get a FREE Evaluation

By submitting this form you agree to be contacted by KirkendallDwyer.com affiliates and/or attorneys regarding your claim. You consent to KirkendallDwyer.com contacting you through the use of text message, phone call, and electronic mail message even if your number is a wireless number or if I am presently listed on a Do Not Call list. My consent does not require purchase.

Call for your FREE consultation with a personal attorney: (877) 503-1595

Pharmaceutical and Medical Device News

SCIENTISTS TRY TO CREATE NEW METHODS TO CATCH DANGEROUS DRUGS

Researchers from the University of Virginia and West Virginia University are trying to use technology to make drugs safer.  They are developing programs that would scour the internet’s patient chatrooms and websites for conversations and comments about adverse drug reactions.  Compiling this data would allow the medical and regulatory communities to address these issues much…..

Posted in Pharmaceutical and Medical Device News,
Tagged FDA, Drug Safety and Research, Prozac,

EXPIRED MEDS: UNSAFE OR ARBITRARY?

In the 1970s, the Food and Drug Administration began requiring that all prescription and over-the-counter medications carry an expiration date.  But with the cost of drugs so high, and drug shortages so commonplace, are there real reasons to be disposing of expired drugs?  There is now good reason to think that we might be throwing…..

Posted in Pharmaceutical and Medical Device News,
Tagged FDA, Drug Research, Drug Safety, Expired Medication,

JAMA STATES THAT FDA TOO QUICK TO APPROVE PRADAXA

Is the FDA’s push to approve drugs more quickly costing too much in the way of patient safety?  According to an article published in the Journal of the American Medical Association by two drug-safety experts, the answer is yes. They cite three drugs, including the controversial blood thinner Pradaxa, that were approved in an accelerated…..

Posted in Pharmaceutical and Medical Device News,
Tagged Blood Thinning Medication, Pradaxa, FDA, Caprelsa, Fingolimod, JAMA,

LOOKING FOR NEW ALZHEIMER DRUG: PROMISE OR BUST?

Finding new treatments for serious diseases like Alzheimer’s is big business, but it has not proven easy for the pharmaceutical industry.  Both Pfizer and Johnson & Johnson both abandoned their Alzheimer’s drugs in late-stage trials, but Eli Lilly is hoping it can be the pioneer.  But is this new treatment just another spin on an…..

Posted in Pharmaceutical and Medical Device News,
Tagged Alzheimer's, Alzheimer's Medication, Pfizer,

THE QUIET RISE OF THE COMPOUNDING PHARMACY

With the recent fungal meningitis outbreak, the compounding pharmacy has come front and center in the line of attack.  People are wondering how these pharmacies have evaded federal regulation, and as a result we are likely to see changes in the way they are regulated. But what has caused the rise of the compounding pharmacy? …..

Posted in Pharmaceutical and Medical Device News,
Tagged FDA, Compounding Pharmacy, Drug Shortage,

PFIZER SETTLES INVESTOR LAWSUIT OVER CELEBREX

Drug giant Pfizer has agreed to pay $164 million to settle a shareholder class action lawsuit over Celebrex, a pain reliever that became the company’s 5th best-selling drug, pulling in $2.5 billion a year. Pfizer was accused of misrepresenting the drug in clinical trials, making it appear safer than it actually was. This is not…..

Posted in Pharmaceutical and Medical Device News,
Tagged Pfizer, Celebrex, Pain Reliver,

A HEART DEVICE WITH KNOWN PROBLEMS NOT RECALLED UNTIL 2011

A defibrillator is a medical device that delivers a shock to the heart when a patient suffers a life-threatening arrhythmia.  To patients with heart problems, this device can be a lifesaver, and its proper functioning a matter of life and death.  But the Riata defibrillator, manufactured by St. Jude Medical, has been having problems with…..

Posted in Pharmaceutical and Medical Device News,
Tagged FDA, Defibrilators, Heart Device, Riata,

ROCHE BEING INVESTIGATED FOR IGNORING SIDE EFFECT COMPLAINTS

The European Medicines Agency, similar to the FDA in the States, is launching infringement proceedings against drug giant Roche.  It is alleged that Roche failed to investigate over 80,000 reports from consumers of adverse effects of drugs sold in the United States. The problem came to the attention of the EMA when a routine inspection…..

Posted in Pharmaceutical and Medical Device News,
Tagged FDA, cancer drugs, European Medicines Agency, Flu vaccine, Roche,

NEW TAINTED DRUGS MEANS MORE MENINGITIS

While it was initially thought that the recent fungal meningitis outbreak was a result of only one tainted steroid, there are reports this week that there are three new cases that are linked to different drugs made by the same compounding pharmacy.  The FDA is investigating, and has not provided any definitive answers yet. The…..

Posted in Pharmaceutical and Medical Device News,
Tagged meningitis, FDA,

DAILY VITAMINS AND THE MOST RECENT HYPE

From advertisements featuring radiant, silver haired couples, to new studies on their efficacy, we hear a lot about vitamins.  Sometimes the news is bad, and sometimes its good.  The results of the most recent study revealed a new good point.  In it, 14,000 men over the age of 50 were studied for over a decade,…..

Posted in Pharmaceutical and Medical Device News,
Tagged JAMA, placebo, Vitamins,